CLOV Looks Promising in Analysts’ Eyes


During the last session, 43M of Clover Health Investments, Corp. (NasdaqGS:CLOV)’s shares were traded. The stock closed at $2.99 per share indicating that it gained $0.39 or 15% during that day which brings the Clover Health Investments, Corp.’s valuation to $1.19B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -89.64% from that peak with a 52-week low of $1.9500, while the S&P 500’s share price change was 7.75%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen growth in its daily volume. The daily volume was of 43M, while in the last 10 days the average was 23.89M and last three months – 14.85M.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 33.98M shares being shorted which translates into 2.59 of a short ratio for CLOV, while in the previous month the shorted shares were 26.25M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 1.19B, Clover Health Investments, Corp. holds a total cash of $615.25M that translates into $1.3 per share, while the total debt is of $27.83M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 121.60%. The current revenue is of $1.36B that is $3.30 per share.

This is a great sign for a bright future.